Craft

DiaSorin

Stock Price

€103.8

2024-10-29

Market Capitalization

€5.4 B

2024-08-26

Revenue

€1.2 B

FY, 2025

DiaSorin Summary

Company Summary

Overview
DiaSorin is a company that develops, produces, and commercializes reagent kits and instruments for diagnosis and research. It specializes in immunodiagnostics, a technology based on detecting antibodies and antigens to measure physiological function markers or show the presence of diseases in human fluid samples, molecular diagnostics offering solutions that identify DNA/RNA sequences in various categories of biological samples, and licensed technologies providing a range of platforms that serve various markets, including biomedical, genome, and proteome research, clinical diagnostics, and the discovery of drugs.
Type
Public
Status
Active
Founded
1968
HQ
Saluggia, IT | view all locations
Website
https://int.diasorin.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Carlo Rosa

    Carlo Rosa, Chief Executive Officer

    • Michele Denegri

      Michele Denegri, Chairman

      • Piergiorgio Pedron

        Piergiorgio Pedron, Chief Financial Officer

      • Chen Even

        Chen Even, Chief Commercial Officer

        Operating MetricsView all

        New Placements (Liaison XL)

        299
        24.1%

        Q2, 2021

        Overall Installed Base (Liaison XL)

        9K
        5.8%

        Q2, 2021

        Manufacturing Facilities

        10

        FY, 2022

        LocationsView all

        21 locations detected

        • Saluggia, Piemonte HQ

          Italy

          Via Crescentino, snc

        • Stillwater, MN

          United States

          1951 Northwestern Ave

        • Macquarie Park, New South Wales

          Australia

          11 Talavera Road

        • Wien, Wien

          Austria

          Schottenring 16/Top 08-10A

        • Anderlecht, Bruxelles

          Belgium

          Bd Paepsem 11

        • San Paolo, SP

          Brazil

          Av. Ermano Marchetti, 1435 - Água Branca

        and 15 others

        DiaSorin Financials

        Summary Financials

        Revenue (FY, 2025)
        €1.2B
        Gross profit (FY, 2025)
        €901.7M
        Net income (FY, 2025)
        €150.0M
        Cash (FY, 2025)
        €165.8M
        EBIT (FY, 2025)
        €228.6M
        Enterprise value
        $6.0B

        Footer menu